Latest Ratios: P/E Ratio -3.2x · EV/EBITDA N/A · ROE -80.0%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $513M | $336M | $28M | $3M | $11M | $10M | $20M | $177M | $539M | — | — |
| Enterprise Value | $336M | $160M | $-57535663 | $-5218656 | $-7236150 | $4M | $35M | $139M | $406M | — | — |
| P/E Ratio → | -3.17 | — | — | — | — | — | — | 32.32 | 8.24 | — | — |
| P/S Ratio | 34.68 | 22.76 | 11.45 | 0.21 | 1.87 | 5.44 | 2.96 | 47.83 | 5.03 | — | — |
| P/B Ratio | 2.18 | 1.69 | 0.20 | 0.31 | 0.91 | 0.55 | 0.43 | 1.40 | 3.85 | — | — |
| P/FCF | 501.13 | 328.95 | 20.45 | — | — | 0.95 | — | — | 6.18 | — | — |
| P/OCF | 435.37 | 285.78 | 20.45 | — | — | 0.95 | — | — | 6.14 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.85 | -23.83 | -0.40 | -1.21 | 2.52 | 5.00 | 37.71 | 3.79 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | 5.34 | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | 5.31 | — | — |
| EV / FCF | — | 156.71 | -42.58 | — | — | 0.44 | — | — | 4.66 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1.9% | -1.9% | 5.1% | 9.6% | 10.1% | 69.0% | 100.0% | 100.0% | 92.1% | 77.5% | 80.2% |
| Operating Margin | -1125.4% | -1125.4% | -357.8% | -108.2% | -54.3% | -1547.1% | -695.7% | -194.6% | 70.7% | 43.3% | 34.8% |
| Net Profit Margin | -913.4% | -913.4% | -391.8% | -10.3% | -280.8% | -1984.5% | -1029.7% | 149.7% | 61.1% | 37.4% | 29.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.0% | -80.0% | -12.8% | -12.9% | -114.0% | -106.5% | -81.6% | 4.2% | 80.1% | 45.7% | 40.8% |
| ROA | -75.6% | -75.6% | -11.6% | -3.3% | -35.7% | -62.1% | -56.1% | 3.3% | 68.1% | 33.8% | 23.8% |
| ROIC | -73.9% | -73.9% | -8.8% | -101.3% | -12.4% | -42.4% | -33.5% | -3.8% | 69.6% | 39.6% | 35.8% |
| ROCE | -98.0% | -98.0% | -11.7% | -135.1% | -22.1% | -63.6% | -44.8% | -5.0% | 92.8% | 52.8% | 47.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | — | — | — | 0.58 | 0.43 | 0.16 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.88 | -0.62 | -0.90 | -1.50 | -0.30 | 0.29 | -0.30 | -0.95 | -0.82 | -0.56 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | -1.74 | -1.92 | -1.86 |
| Debt / FCF | — | -172.24 | -63.03 | — | — | -0.51 | — | — | -1.52 | -2.43 | -1.13 |
| Interest Coverage | — | — | — | — | -3.98 | -13.42 | -17.76 | — | — | — | — |
Net cash position: cash ($176M) exceeds total debt ($81737)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.20 | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 | 4.21 | 3.68 | 6.84 | 5.65 | 1.15 |
| Quick Ratio | 14.20 | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 | 4.21 | 3.68 | 6.84 | 5.65 | 1.15 |
| Cash Ratio | 12.76 | 12.76 | 23.70 | 0.68 | 0.36 | 1.05 | 0.54 | 2.16 | 5.56 | 3.94 | 0.93 |
| Asset Turnover | — | 0.07 | 0.02 | 0.64 | 0.10 | 0.06 | 0.09 | 0.02 | 0.65 | 0.81 | 0.53 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 11.1% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 353.3% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | 3.1% | 12.1% | — | — |
| FCF Yield | 0.2% | 0.3% | 4.9% | — | — | 105.3% | — | — | 16.2% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 0.7% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 11.8% | 0.0% | — | — |
| Shares Outstanding | — | $285M | $24M | $8M | $7M | $5M | $5M | $6M | $5M | $5M | $5M |
Unsustainable operational cash burn
Based on reported financial data, AHG trades at a P/S ratio of 34.68, which appears significantly disconnected from its negative gross margins and suggests that investors are pricing the company as a speculative asset rather than a traditional service provider within the credit services sector.
The forward P/E of 0.38 is mathematically anomalous and likely reflects extreme market skepticism regarding the company's ability to achieve positive earnings. Investors should monitor whether this valuation gap persists as the company attempts to pivot its business model, as the current price-to-book ratio of 2.18 suggests the market is assigning value primarily to the cash balance rather than the underlying operations.
As reported in recent financial statements, AHG's gross margin has deteriorated to -6.0% by 2025Q4, indicating that the direct costs of product procurement and fulfillment are currently exceeding the revenue generated, which highlights a fundamental lack of pricing power in its core e-commerce operations.
The operating margin of -21.1% further underscores the disconnect between the company's revenue generation and its fixed cost base. This trend suggests that the current business model is not yet scalable, and any path to profitability would require a radical shift toward higher-margin consultancy services rather than subsidized product trading.
According to historical data, AHG's ROIC has remained consistently negative, reaching -31.0% in 2025Q4, which suggests that the company is currently destroying shareholder value rather than compounding it through its recent strategic investments and operational activities.
The persistent negative return on capital reflects the company's inability to generate sufficient operating income to cover the cost of its asset base. This trend warrants further investigation into whether the recent rebranding and pivot to health services can reverse this decay or if the capital base will continue to be eroded by ongoing operational losses.
Based on reported figures, AHG's asset turnover ratio remains extremely low at 0.02, indicating that the company is failing to generate meaningful revenue from its asset base compared to industry peers in the financial services and credit sectors.
The erratic nature of the company's DSO, which has fluctuated significantly over the last ten quarters, suggests that the firm lacks a stable or efficient collection process. This inefficiency in working capital management appears to be a structural drag on the company's ability to convert its platform activity into sustainable cash flow.
The most commonly misapplied metric for AHG is the P/E ratio, which is fundamentally misleading for a company with negative earnings and a business model currently transitioning from e-commerce to health services, as it obscures the company's true status as a cash-heavy, pre-profit entity.
Analysts should instead focus on the cash burn rate and the net cash position relative to the enterprise value to assess the company's survival runway. Using traditional valuation multiples in this context risks ignoring the reality that the company is currently functioning more like a venture-backed startup than a mature financial services firm.
Includes 30+ ratios · 11 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AHG stock.
Akso Health Group's current P/E ratio is -3.2x. The historical average is 20.3x.
Akso Health Group's return on equity (ROE) is -80.0%. The historical average is -22.5%.
Based on historical data, Akso Health Group is trading at a P/E of -3.2x. Compare with industry peers and growth rates for a complete picture.
Akso Health Group has -1.9% gross margin and -1125.4% operating margin.